The groundbreaking rise of Viagra has firmly established as a example of pharmaceutical success, yet its position within the broader sector now triggers questions about long-term gains. Alternative versions are undercutting patent protection , causing worries that supporting companies heavily reliant to Viagra's once-dominant position could be a pr